spasticity
Neurology · 2008–2026
3decisions
3medicines
0carried consumer input
0individual submissions
No submission for this condition has carried consumer input, including the 2 made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| incobotulinumtoxinA Moderate to severe spasticity of the lower limb in adults following stroke, traumatic brain injury, or spinal cord injury. | Mar 2026 | Recommended with restriction | no section in document |
| baclofen Treatment of severe chronic spasticity of cerebral origin, due to multiple sclerosis, due to spinal cord injury, or due to spinal cord disease, in patients who… | Jul 2017 | Recommended with restriction | none received |
| botulinum toxin type A Treatment of moderate to severe spasticity of the lower limb in ambulatory adults following a stroke as second line therapy when standard management has failed… | Jul 2008 | Not recommended | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.